Need a specific person's email?
Browse ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company's employee directory (about 367 employees) and reveal verified emails free.
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company's most common email format is First.Last@imclone.com (ex. John.Doe@imclone.com), used for 83% of imclone.com addresses. ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company uses 4 email patterns.
| Format | Example | Share of imclone.com |
|---|---|---|
| First.Last@imclone.comMost common | John.Doe@imclone.com | |
| FirstL@imclone.com | JohnD@imclone.com | |
| Last_First@imclone.com | Doe_John@imclone.com | |
| Last.F@imclone.com | Doe.J@imclone.com |
Browse ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company's employee directory (about 367 employees) and reveal verified emails free.
Biotechnology ResearchUnited States201-500 Employees
ImClone Systems is a United States–based biotechnology company focused on cancer research and development. It develops and brings to market targeted biologic medicines intended to address the medical needs of patients with various cancers, operating as a fully integrated, global biopharmaceutical organization. Since 2008, the company has been a wholly owned subsidiary of Eli Lilly and Company, aligning it with Lilly’s oncology initiatives. The company has emphasized monoclonal antibodies as a therapeutic approach for cancer. In 2020, reporting notes that ImClone is actively developing monoclonal antibodies for cancer treatment, reflecting ongoing progress within its oncology portfolio.
Most common format
First.Last@imclone.com
Example: John.Doe@imclone.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.